In article <2oj0tr$j3g at bambi.zdv.uni-mainz.de>, dauscher at mzdmza.zdv.uni-mainz.de writes:
> Can anyone tell me, whether the number of Creutzfeld-Jacob-Patients
> in the European Countries has been rising in the last few years?
> Peter
--
I've read that patients on GH therapy (non-recombinant) have
had increased incidence if CJ. This has been attributed to
the GH being infected with the virus. As we now have access
to rhGH (recombinant human growth hormone) this is a moot
point.
John T. Robicheau
Robich at DrugInfonet.Pharm-Epid.Pitt.Edu